As shown in Figure 7A, renal subcapsular injection of hyper‐IL‐6 1 week after induction of nephropathy resulted in a dramatic dose‐dependent prevention of fibrosis 3 months later (using 100 ng hyper‐IL‐6 per injected kidney, but not 10 ng). This evidence concerns the gene IL6 and kidney disorder.